Empowering

Medical Devices

& Patients

with Conversational AI

Partners & Investor Portal

About Us

MedVoice Al™ brings together the clinical excellence of Mayo Clinic with patented technologies developed by researchers at Carnegie Mellon University.

We develop scalable systems that empower in-home medical devices to guide patients throughout their treatment.

Meet the Team

Market Trends & Problems

Trends

The COVID pandemic drove the need for Remote Patient Care

Medicare & Private Insurance reimbursement expanded coverage for Remote Patient Monitoring (RPM)
16 million people live with COPD in the US; over 250 million people globally
Hospital to Home is a growing healthcare trend

Problems

COPD is 3rd leading cause of death; improve monitoring to saves live
$49 billion annual healthcare costs due to COPD driven by delayed treatment, poor medication adherence, and unnecessary hospital visits
1 million plus ER visits in the US per year attributed to people with COPD symptoms
Most medical devices are not designed for home use and are not being used properly in a remote setting

Initial Market: COPD

COPD is becoming the leading

cause of death worldwide

Compliance to treatment is essential to disease management
Compliance rates are reportedly under 50%
Communication and education can address compliance obstacles

A simple conversational guided interaction would:

optimize home care
address the impediments to compliance prevent exacerbations lower costs
Prevent exacerbations
Lower costs

MEDVOICE AI Solutions

Today's medical devices have Al capabilities, but they do not converse with the patients and help them to remotely use devices traditionally intended for professional/in hospital use.

The patented MedVoice Al system gathers information about the COPD patient's health status, medical history, and comorbidities.

Imbedded conversational Al enables the device to talk patients through using the device, interpreting the results and helping the patient and their caregivers understand what it means.

Over time, machine learning will yield vital insights for COPD patient experiences and support continuous system improvements.